• Practice
  • About 15 min
  • 5 practice questions

Drug-target interactions: inhibitors, receptors and the traps

Answer exam-style questions on enzyme inhibition, receptor agonists and antagonists, and drug classification, and avoid the wording traps that cost marks.

If something looks wrong, please tell us.

Questions on how drugs act are short, but each one hides a trap in a single word: 'active site' versus 'allosteric site', 'agonist' versus 'antagonist', 'pharmacological effect' versus 'drug action'. This lesson revises the theory quickly and then trains you to read those words precisely, which is where the marks are.

Enzymes: two jobs, two ways to block them

An enzyme does two jobs: it holds the substrate in its active site, and it catalyses the reaction, often by providing acidic or basic groups that attack the substrate. Drugs that block enzymes are enzyme inhibitors. A competitive inhibitor resembles the substrate and occupies the active site, so substrate and drug compete. A drug that binds at a different site, the allosteric site, changes the shape of the active site so the substrate cannot fit; adding more substrate does not help. If the drug forms a strong covalent bond with the enzyme, the inhibition is irreversible, and the body must make new enzyme.

Receptors: the message, not the messenger

Receptors sit in cell membranes with their binding site facing outside. A chemical messenger (a neurotransmitter or hormone) binds, the receptor changes shape, and the message is passed inside the cell; the messenger then leaves and the receptor returns to its original shape. Because receptors are specific, the body has many kinds, and a drug designed for one kind need not touch another. A drug that binds and switches the receptor on is an agonist (useful when natural messenger is lacking). A drug that binds and blocks without switching on is an antagonist (useful when the message must be stopped).

Classification traps

Four bases of classification
BasisUseful toExample and trap
Pharmacological effectDoctors: a full range of drugs for a problemAnalgesics, antiseptics
Drug actionGrouping by the biochemical process affectedAll antihistamines block histamine, even though histamine acts in many places
Chemical structureChemists; but similar structure does not guarantee similar actionSulphonamides share a structure
Molecular targetMedicinal chemists, most useful to themDrugs binding the same enzyme or receptor

Worked example 1

Statement: 'Adding a large excess of substrate overcomes the effect of a drug that binds at the allosteric site.' True or false? Step 1: an allosteric drug binds away from the active site and changes its shape. Step 2: excess substrate cannot push the drug out of a site the substrate does not use. Step 3: so the shape stays wrong whatever the substrate concentration. The statement is false; it is true only for a competitive inhibitor.

Worked example 2

A messenger is produced in too small an amount, so a response is weak. Which drug type and which binding behaviour do you want? Step 1: we need more response, so the drug should switch the receptor on: an agonist. Step 2: it must bind the same receptor as the natural messenger, otherwise it reaches the wrong cells. Step 3: an antagonist would make the response weaker still. Answer: an agonist for that specific receptor. Quick check for any option: does it increase or decrease the message?

Speed method for 'which is incorrect' questions

Write a one-word tag beside each option: 'active', 'allosteric', 'covalent', 'agonist', 'antagonist'. Then test each tag against the rule: only competitive (active site) inhibition is overcome by substrate; only covalent binding is irreversible; only agonists increase the response. The incorrect option is usually the one that gives a property to the wrong tag.

Competitive: active site, beaten by excess substrate. Allosteric: other site, changes shape. Covalent: irreversible. Agonist: switches on. Antagonist: blocks.

Key takeaways

  • Enzymes hold the substrate and catalyse its reaction; inhibitors interfere with either.
  • Excess substrate overcomes only competitive inhibition.
  • Receptors are specific, which is why selective drugs are possible.
  • Classification by molecular target is the most useful to medicinal chemists.

Check your understanding

  1. 1. A drug forms a strong covalent bond with an enzyme. The body recovers enzyme activity by:

    1. Adding more substrate
    2. Making new enzyme
    3. Diluting the drug
    4. Heating the enzyme
    Show answer

    Answer: B. Covalent binding is irreversible, so the blocked enzyme cannot be freed; the body must synthesise new enzyme molecules.

  2. 2. Which inhibition can be overcome by increasing the substrate concentration?

    1. Allosteric
    2. Irreversible covalent
    3. Competitive
    4. Every kind
    Show answer

    Answer: C. Only a competitive inhibitor competes for the active site, so more substrate wins it more often.

  3. 3. Antagonists are useful when:

    1. The message must be blocked
    2. The natural messenger is lacking
    3. An enzyme must be made faster
    4. Bacteria must be killed
    Show answer

    Answer: A. An antagonist binds the receptor without activating it, so it blocks an unwanted message.

  4. 4. Classification of drugs on the basis of molecular targets is most useful to:

    1. Patients
    2. Pharmacists selling medicines
    3. Hospital accountants
    4. Medicinal chemists
    Show answer

    Answer: D. Grouping by molecular target (the enzyme or receptor bound) helps medicinal chemists design new drugs.

  5. 5. Which statement is incorrect?

    1. Receptors show selectivity for messengers
    2. An allosteric inhibitor changes the shape of the active site
    3. Excess substrate removes an allosteric inhibitor
    4. Agonists mimic the natural messenger
    Show answer

    Answer: C. An allosteric inhibitor binds at another site, so extra substrate cannot displace it. The other three statements are correct.

Privacy · Terms · Refunds · Delivery